MapLight Therapeutics

MapLight Therapeutics is a biopharmaceutical company that discovers and develops new treatments for patients with central nervous system disorders. MapLight's mission is to address the significant unmet medical needs of these patients by developing innovative targeted therapies to treat their specific clinical manifestations. The company’s circuit-based approach and proprietary discovery platform aim to bring more effective and safer treatments to these patients through the rational development of therapies targeting defective brain circuits. The company’s platform includes STARmap (Spatial Transcriptomics And RNA Mapping) and optogenetics, which enable the identification of circuit-specific targets and validate that target modulation can improve disease.